70
Growth Score in past quarter
pts
Heat Score 70 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
309641
Proteris Biotech develops solutions for disease prevention and treatment, with a lead product for dry eye disease.
- M. Elizabeth Fini: Co-Founder & Chief Scientific Officer
- John C. Fini: Founder & CEO
About the Company
Proteris Biotech is a company in the biotechnology industry. The company focuses on developing solutions that utilize the body's natural protective responses for the prevention and treatment of diseases. One of their notable achievements is being awarded a Small Business Technology Transfer (STTR) grant by the National Eye Institute of the
National Institutes of Health (NIH). Proteris Biotech's lead product is Protearin, which is used for the treatment of dry eye disease.
Women Founded